Precipio, Inc.
PRPO · XNASCIK 1043961fmd_0QHPGRTFNPZRPV513W4TQ8XMARManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 2 | 3 | 3 | 6 | 9 | 9 | 15 | 19 | 24 |
| Cost of revenue | 1 | 1 | 3 | 3 | 5 | 6 | 7 | 9 | 11 | 13 |
| Gross profit | 1 | 0 | 0 | 0 | 1 | 2 | 3 | 6 | 8 | 11 |
| Research and development | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 |
| Selling, general and administrative | 2 | 6 | 9 | 10 | 10 | – | – | – | – | – |
| Total operating expenses | 2 | 16 | 14 | 11 | 10 | 12 | 15 | 14 | 12 | 12 |
| Operating income | (2) | (16) | (14) | (11) | (9) | (10) | (13) | (8) | (4) | (1) |
| Other non-operating income (expense) | 0 | – | – | – | – | – | – | – | (0) | 1 |
| Income before taxes | (2) | (21) | (16) | (13) | (11) | (9) | (12) | (6) | (4) | (0) |
| Income tax expense | 0 | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (2) | (21) | (16) | (13) | (11) | (9) | (12) | (6) | (4) | (0) |
| Net income | (2) | (21) | (16) | (13) | (11) | (9) | (12) | (6) | (4) | (0) |
| Net income to common shareholders | (4) | (33) | (20) | (13) | (14) | (9) | (12) | (6) | – | – |